These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 7195291

  • 21. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
    Ali-Osman F, Berger MS, Rajagopal S, Spence A, Livingston RB.
    Cancer Res; 1993 Dec 01; 53(23):5663-8. PubMed ID: 8242621
    [Abstract] [Full Text] [Related]

  • 22. Monitoring uptake of ellipticine and its fluorescence lifetime in relation to the cell cycle phase by flow cytometry.
    Sailer BL, Valdez JG, Steinkamp JA, Darzynkiewicz Z, Crissman HA.
    Exp Cell Res; 1997 Oct 10; 236(1):259-67. PubMed ID: 9344606
    [Abstract] [Full Text] [Related]

  • 23. Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumors.
    Masunaga S, Ono K, Akaboshi M, Takagaki M, Kinashi Y, Suzuki M, Abe M.
    Radiat Med; 1997 Oct 10; 15(1):37-43. PubMed ID: 9134583
    [Abstract] [Full Text] [Related]

  • 24. Radiosensitization of GL261 glioma cells by tetraiodothyroacetic acid (tetrac).
    Hercbergs A, Davis PJ, Davis FB, Ciesielski MJ, Leith JT.
    Cell Cycle; 2009 Aug 15; 8(16):2586-91. PubMed ID: 19597333
    [Abstract] [Full Text] [Related]

  • 25. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
    Pogrebniak A, Schemainda I, Azzam K, Pelka-Fleischer R, Nüssler V, Hasmann M.
    Eur J Med Res; 2006 Aug 30; 11(8):313-21. PubMed ID: 17052966
    [Abstract] [Full Text] [Related]

  • 26. Enhancement of X-ray induced cytotoxicity by neocarzinostatin in asynchronous and synchronous rat 3Y1 fibroblasts.
    Nakamura K.
    Fukuoka Igaku Zasshi; 1993 Aug 30; 84(8):363-7. PubMed ID: 8375797
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation of cell-killing effects of 1-beta-D-arabinofuranosylcytosine and daunorubicin by a new computer-controlled in vitro pharmacokinetic simulation system.
    Kishi S, Goto N, Nakamura T, Ueda T.
    Cancer Res; 1999 Jun 01; 59(11):2629-34. PubMed ID: 10363985
    [Abstract] [Full Text] [Related]

  • 34. Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines.
    Herring CJ, Deans B, Elder RH, Rafferty JA, MacKinnon J, Barzilay G, Hickson ID, Hendry JH, Margison GP.
    Br J Cancer; 1999 Jun 01; 80(7):940-5. PubMed ID: 10362100
    [Abstract] [Full Text] [Related]

  • 35. Enhancement of DNA repair activity in rat-liver cells exposed to cisplatin.
    Hibino Y, Kamiuchi S, Kusashio E, Sugano N.
    Biochem Mol Biol Int; 1996 Apr 01; 38(5):973-9. PubMed ID: 9132166
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
    Kratochwil NA, Zabel M, Range KJ, Bednarski PJ.
    J Med Chem; 1996 Jun 21; 39(13):2499-507. PubMed ID: 8691447
    [Abstract] [Full Text] [Related]

  • 38. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I, Ling YH, al-Baker S, Khokhar AR, Perez-Soler R.
    Cancer Res; 1993 Oct 15; 53(20):4913-9. PubMed ID: 8402681
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS, Mills GB, Khokhar AR, Bast RC, Siddik ZH.
    Clin Cancer Res; 1999 Mar 15; 5(3):655-63. PubMed ID: 10100719
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.